HIBI reviews behavioral and social science applications focusing on individual- and interpersonal-level studies of the prevention of HIV exposure and infection and those living with HIV.
HIBI includes studies examining factors at the individual and social levels related to reducing HIV associated risk behaviors and fostering HIV prevention as well as studies examining HIV testing, engagement, retention and re-engagement across the HIV care continuum. It also reviews studies on the effects of HIV infection and AIDS on behavior, cognitive and social functioning, and various health outcomes including substance use, mental health disorders, pain management, and self-management of health care.
The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
The membership panel is a list of chartered members only.
- Social, cultural and behavioral influences related to HIV exposure and associated risk behaviors, including the development and testing of behavioral interventions at the individual, dyad, and/or social support network level.
- Social, cultural and behavioral factors related to improving ART adherence, engagement and retention in care, achieving durable viral suppression, and the quality of life for those living with HIV.
- The development and testing of interventions for preventing HIV transmission, promoting HIV testing and reducing practices and behaviors that lead to HIV transmission for individuals and dyads.
- Behavioral and social aspects of treatment and treatment as prevention, including studies involving PrEP adoption and adherence for people at risk for HIV infection.
- Studies examining the use of technology to improve the health outcomes of individuals at risk for HIV or persons living with HIV.
- Studies examining substance use and related behaviors in people at risk for HIV or persons living with HIV.
- Studies examining the association between mental health (e.g., depression, anxiety, trauma, and stigma) and risk behaviors for HIV or the impacts of living with HIV at the individual or interpersonal level.
Shared Interests and Overlaps
- Studies addressing the qualitative and quantitative evaluation of HIV prevention or HIV care continuum interventions at the individual level will be reviewed by HIBI, while studies of interventions at the community or population level will be reviewed by PPAH. Studies with a combination of both community and individual level interventions are assigned based on the principal outcomes of the proposed research.
- Clinic based studies addressing HIV prevention and/or HIV care involving interventions primarily at the individual level are reviewed in HIBI, while clinic based studies involving interventions primarily at the community level are reviewed in PPAH.
- Developmental and/or small-scale implementation science studies to establish appropriate measures and/or populations, for example, may be reviewed in HIBI.
Only applications in which there is a clear and compelling HIV/AIDS research component in the proposed research plan are eligible for the AIDS deadlines and review in HIBI and other AARR study sections. Those deemed insufficiently related to HIV/AIDS are assigned to other study sections and must be submitted in time to meet the regular non-AIDS application due dates. Applicants might consider requesting study sections in the following integrated review groups (IRGs):
Risk, Prevention and Health Behavior (RPHB): RPHB research interests include behavioral interventions and risk factor modification studies, and psychological and biobehavioral responses to disease screening and management.
Healthcare Delivery and Methodologies (HDM): HDM reviews clinical, community, and population research studies which examine the sociocultural, economic, environmental, and infrastructure factors that influence the delivery of health care, patient outcomes, population health, and health policies.